Portal de investigación
INVESTIGACION COOPERATIVA DE ENFERMEDADES RESPIRATORIAS
Datos básicos
- NumeroConcesion:
- PI05/0583
- Año inicial:
- 2006
- Año final:
- 2015
Objetivos del proyecto
FINALIZADO
Documentos
- No hay documentos
Participantes
Financiadores
Resultados del Proyecto
Acute and sustained endothelial damage in COVID-19
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.OA3966. 2021
Acute and Sustained IL-17a Response in Bronchiectasis Exacerbations as Marker of Chronic Inflammation
Mendez, R.; (...); Menendez, R.
Meeting Abstract. 2020
Acute and sustained increase in endothelial biomarkers in COVID-19.
Méndez R; (...); Menéndez R
Article. 10.1136/thoraxjnl-2020-216797. 2021
Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy
Oscanoa Huaman, Patricia Elena; (...); Torres Marti, Antoni
Meeting Abstract. 10.1183/13993003.congress-2019.PA2866. 2019
Acute Exacerbations Of COPD And COPD Patients With Community-Acquired Pneumonia: Characteristics, Systemic Inflammatory Response And Outcomes
Huerta, A.; (...); Torres, A.
Article. 2013
Age-related risk factors for bacterial aetiology in community-acquired pneumonia
Sahuquillo-Arce JM; (...); Torres A
Article. 10.1111/resp.12851. 2016
Antibiotic Compliance And Timing In Community-Acquired Pneumonia With Sepsis
Menendez, R.; (...); Ruiz, J.
Article. 2011
Antibiotic choice, route and duration: minimising the harm associated with antibiotics
Menendez, R, Montull, B, Mendez, R
Article. 10.1183/1025448x.10004113. 2014
Asthma Exists in Older People too.
Perpiñá Tordera M, Álvarez Gutiérrez FJ, Blanco Aparicio M
Editorial Material. 10.1016/j.arbres.2022.02.010. 2022
BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES.
Fernández LS; (...); Jorge RZ
Article. 10.1016/j.ijid.2021.11.023. 2022
Bacteremia in non-HIV community acquired pneumonia
Cilloniz, Catia; (...); Menendez, Rosario
Article. 2013
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia.
Cillóniz C; (...); Torres A
Article. 10.1016/j.jinf.2012.04.009. 2012
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1038/s41598-024-62718-4. 2024
Biomarkers and community-acquired pneumonia: tailoring management with biological data.
Torres A; (...); Menéndez R
Article. 10.1055/s-0032-1315638. 2012
Biomarkers As Predictors Of Early And Long-Term Cardiovascular Events In Community-Acquired Pneumonia. Preliminary Results
Mendez, R.; (...); Menendez, R.
Meeting Abstract. 2016
Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
Menéndez R; (...); Torres A
Article. 10.1136/thx.2008.105312. 2009
Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac).
Méndez R, Aldás I, Menéndez R
Review. 10.3390/jcm9020549. 2020
Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes.
Wang X; (...); Barreiro E
Article. 10.3390/biomedicines10051044. 2022
Bronchiectasis and Multidrug-resistant Microorganisms: The Ideal Niche?
Mendez, R, Amara, I, Menendez, R
Editorial Material. 10.1016/j.arbres.2018.02.018. 2018
Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease?
Modesto-Alapont, M; (...); Perpina-Tordera, M
Article. 10.1016/S1579-2129(06)60131-6. 2006
Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
Méndez R; (...); Menéndez R
Article. 10.1016/j.chest.2021.10.013. 2021
Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study.
Scioscia G; (...); Torres A
Article. 10.3390/jcm8111950. 2019
Clinical Stability and Biomarkers in Community-Acquired Pneumonia.
Menendez, R.; (...); Torres, A.
Article. 2009
Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers
Menendez, R; (...); Torres, A
Article. 10.1016/j.chest.2019.06.040. 2019
Community-acquired pneumonia with severe sepsis: Etiology and prognosis
Montull, Beatriz; (...); Menendez, Rosario
Article. 2013
Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2020 Update
MENENDEZ, R; (...); Torres, A
Review. 10.1016/j.arbres.2020.01.014. 2020
Comorbidities And Initial Severity In Community-Acquired Pneumonia (cap)
Menendez, R.; (...); Torres, A.
Meeting Abstract. 2015
Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma.
Tedim AP; (...); Torres A
Article. 10.1111/eci.13501. 2021
Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.
Menéndez R; (...); Ruiz-Manzano J
Article. 10.1371/journal.pone.0037570. 2012
Corticosteroids and pneumonia - targeting the ideal candidate
Menendez, R, Amara-Elori, I, Mendez, R
Editorial Material. 10.1080/17476348.2018.1502085. 2018
Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+Years in Spain
Rodríguez González-Moro JM; (...); Antoñanzas F
Article. 10.1007/s40261-015-0345-z. 2016
COST-EFFECTIVENESS OF A 13-VALENT CONJUGATE PNEUMOCOCCAL VACCINATION PROGRAM IN COPD PATIENTS AGED 50+YEARS IN SPAIN
Rodríguez-GonzálezMoro JM; (...); Antoñanzas F
Meeting Abstract. 10.1016/j.jval.2015.09.1424. 2015
COVID-19 in young and middle aged adults. Predictors of poor evolution and clinical differences
Tabernero Huguet, Eva; (...); Zalacain Jorge, Rafael
Meeting Abstract. 10.1183/13993003.congress-2021.OA88. 2021
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
Tabernero E; (...); Zalacain R
Article. 10.1007/s15010-021-01684-9. 2021
COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach.
Garcia-Vidal, Carolina; (...); Soriano, Alex
Article. 10.1002/jmv.70276. 2025
C-Reactive Protein at Discharge, Diabetes Mellitus and >= 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Crisafulli E; (...); Menéndez R
Article. 10.3109/15412555.2014.933954. 2015
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON).
Posadas T; (...); Martinez-García MA
Article. 10.1016/j.arbres.2019.12.017. 2021
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations.
Aliberti S; (...); Chalmers JD
Article. 10.1016/S2213-2600(21)00277-0. 2021
Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia.
Menéndez R; (...); Torres A
Article. 10.1378/chest.11-1446. 2012
Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis
Veiga, Beatriz Montull; (...); Ruiz-Manzano, Juan
Article. 2012
Determinants of hospital costs in community-acquired pneumonia.
Reyes S; (...); Ramírez P
Article. 10.1183/09031936.00083107. 2008
Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study.
Ramírez P; (...); Ramírez P
Article. 10.1186/cc10015. 2011
Differences in Nutritional Status and Inflammatory Biomarkers between Female and Male Patients with Bronchiectasis: A Large-Cohort Study
Wang, XJ; (...); Barreiro, E
Article. 10.3390/biomedicines9080905. 2021
Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia.
Aldás I; (...); Grupo NEUMONAC
Article. 10.1016/j.arbres.2019.10.009. 2019
Early profiling of low-risk SARS-CoV-2 pneumonia for ward allocation
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.PA3659. 2021
Early recognition of low-risk SARS-CoV-2 pneumonia: A model validated with initial data and IDSA/ATS minor criteria.
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1016/j.chest.2022.05.013. 2022
Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia.
Menéndez R; (...); Vallterra J
Article. 10.1183/09031936.00052506. 2007
Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia.
Torres A; (...); Niederman MS
Article. 10.3390/jcm8091461. 2019
Effect of corticosteroids on inflammatory markers in patients with severe cap and high inflammatory response according to presence of lymphopenia
Ceccato, Adrian; (...); Torres, Antoni
Meeting Abstract. 10.1183/13993003.congress-2019.PA2911. 2019
Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; (...); Menéndez Villanueva R
Article. 10.1016/j.rmed.2007.04.018. 2007
Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.
González-Jiménez P; (...); Méndez R
Article. 10.3390/biomedicines12102413. 2024
Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms241713194. 2023
Excessive variability in the performance and interpretation of the metacholine bronchial challenge test
Moragon, EM, de Llano, LP, Perpina, M
Letter. 10.1016/j.arbres.2016.05.001. 2016
Expert consensus recommendations for the management of asthma in older adults.
Perpiñá M; (...); Blanco-Aparicio M
Practice Guideline. 10.1016/j.medcli.2021.04.028. 2021
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda
Article. 10.3390/v15071449. 2023
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study
Menendez, R; (...); Torres, A
Article. 10.1186/s12931-017-0659-x. 2017
Factors associated with inflammatory cytokine patterns in community-acquired pneumonia.
Martínez R; (...); Torres A
Article. 10.1183/09031936.00040710. 2011
Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
Scioscia, G.; (...); Torres, A.
Article. 10.1016/j.arbres.2022.04.008. 2022
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis
Scioscia, Giulia; (...); Torres, Antoni
Meeting Abstract. 10.1183/13993003.congress-2020.3331. 2020
From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment
Ramirez P; (...); Torres A
Article. 10.1186/s13054-016-1342-1. 2016
Guidelines for Severe Uncontrolled Asthma
Serrano, CC; (...); Hernandez, GG
Article. 10.1016/j.arbres.2014.12.007. 2015
Healthcare-associated pneumonia (HCAP): clinical features and biomarkers
Polverino, E.; (...); Torres, A.
Article. 2010
Herpes Zoster Virus: Should Patients With Chronic Respiratory Diseases Be Vaccinated?
Menendez, Rosario, Gonzalez-Jimenez, Paula, Mendez, Raul
Editorial Material. 10.1016/j.arbres.2023.07.012. 2023
Immune treatment in COVID-19.
Menendez, Rosario; (...); Mendez, Raul
Article. 10.37201/req/s01.14.2022. 2022
Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis.
Garcia Clemente, Marta; (...); Martínez-García MÁ
Article. 10.3390/jcm11143960. 2022
Impact of guidelines on outcome: the evidence.
Martínez R; (...); Menéndez R
Article. 10.1055/s-0029-1202936. 2009
Impact of microbial ecology on accuracy of surveillance cultures to predict multidrug resistant microorganisms causing ventilator-associated pneumonia
Lopez-Ferraz C; (...); Torres A
Article. 10.1016/j.jinf.2014.05.011. 2014
Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia.
Bronte, O.; (...); Espana, P. P.
Article. 10.1016/j.scitotenv.2023.164877. 2023
Impact of Time to Intubation on Mortality and Pulmonary Sequelae in Critically Ill COVID-19 Patients: A Prospective Cohort
Gonzalez, J.; (...); Barbe, F.
Meeting Abstract. 2022
Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
Campos, Catia Cilloniz; (...); Soriano, Alex
Meeting Abstract. 10.1183/13993003.congress-2021.PA1753. 2021
Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis.
Cilloniz, Catia; (...); Soriano, Alex
Article. 10.1007/s10096-021-04378-0. 2022
Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept.
Gil-Perotin S; (...); Bonastre J
Article. 10.1186/cc11357. 2012
IN MEMORIAM To Julio Ponce, has works published, Doctor
Garrigues, V, Perpina, M, Marti-Bonmati, L
Biographical-Item. 10.1016/j.gastrohep.2019.02.001. 2019
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.
García-Ortega A; (...); Martínez-García MÁ
Article. 10.1016/j.jinf.2021.01.003. 2021
Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia.
Moret I; (...); Menéndez R
Article. 10.1183/09031936.00190410. 2011
Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
Ramírez P; (...); Torres A
Article. 10.1097/CCM.0b013e3182257445. 2011
Influence of environmental conditions and pollution on the incidence of Streptococcus pneumoniae infections.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1183/23120541.00014-2017. 2017
Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: A prospective clinical study
Ferrer M; (...); Menéndez R
Article. 10.1111/resp.12324. 2014
Inhaled Corticosteroids Do Not Influence the Early Inflammatory Response and Clinical Presentation of Hospitalized Subjects With COPD Exacerbation
Crisafulli E; (...); Torres A
Article. 10.4187/respcare.03036. 2014
Initial and Residual Cardiovascular Damage Remaining at Day 30 in Community-acquired Pneumonia
Ocana, R. Mendez; (...); Menendez, R.
Meeting Abstract. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6241. 2024
Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms
Mendez, R; (...); Torres, A
Article. 10.1164/rccm.201709-1908OC. 2018
Initial management of pneumonia and sepsis: factors associated with improved outcome.
Menéndez R; (...); Ruiz-Manzano J
Article. 10.1183/09031936.00188710. 2012
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Mendez, Raul; (...); NEUMONAC and RECOVID
Article. 10.3389/fmed.2023.1236142. 2023
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
González J; (...); Barbé F
Article. 10.1016/j.arbres.2022.12.017. 2023
Kinetics Of Biomarkers Depends On Onset Of Symptoms In Community-Acquired Pneumonia
Mendez, R; (...); Torres, A
Meeting Abstract. 2017
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact.
Garcia-Vidal C; (...); Soriano A
Article. 10.1007/s40121-024-00938-x. 2024
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Bekki, Amina; (...); Angel Martinez-Garcia, Miguel
Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021
Long-term Mortality in COVID-19 and Community-Acquired Pneumonia: A One-year Follow-up Study
Ocana, R. Mendez; (...); NEUMONAC RECOVID
Meeting Abstract. 2023
Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study.
Mendez, Raul; (...); Menendez, Rosario
Letter. 10.1111/joim.13389. 2022
Lung inflammatory pattern and antibiotic treatment in pneumonia
Lorenzo MJ; (...); Menéndez R
Article. 10.1186/s12931-015-0165-y. 2015
Lymphocyte Subpopulations in Community-Acquired Pneumonia: Role of Cell-Mediated Immunity
Mendez, R; (...); Menendez, R
Meeting Abstract. 2018
Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
Bermejo-Martin, JF; (...); NEUMONAC group
Article. 10.1016/j.ebiom.2017.09.023. 2017
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
Bermejo-Martin, JF; (...); Torres, A
Letter. 10.1016/j.jinf.2020.02.029. 2020
Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality
Mendez, R; (...); Torres, A
Article. 10.1016/j.jinf.2019.04.006. 2019
Machine-Learning Model for Mortality Prediction in Patients with Community-acquired Pneumonia: Development and validation study.
Cilloniz, Catia; (...); Torres, Antoni
Article. 10.1016/j.chest.2022.07.005. 2022
Markers of treatment failure in hospitalised community acquired pneumonia.
Menéndez R; (...); Torres A
Article. 10.1136/thx.2007.086785. 2008
Microbial aetiology and outcomes of CAP in bronchiectatic patients
Polverino, Eva; (...); Torres, Antoni
Article. 2013
Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
Polverino E; (...); Rello J
Article. 10.1136/thoraxjnl-2013-203828. 2013
miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis.
Arroyo AB; (...); Martínez C
Article. 10.3324/haematol.2019.240226. 2021
Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms24076690. 2023
Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia
Jimenez, PG; (...); MENENDEZ, R
Meeting Abstract. 10.1183/13993003.congress-2020.2341. 2020
New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality A Validation and Clinical Decision-Making Study
Ranzani, OT; (...); Torres, A
Article. 10.1164/rccm.201611-2262OC. 2017
Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality
Garcia-Garcia, Fernando; (...); Jorge, Rafael Zalacain
Article. 10.1186/s41479-024-00132-0. 2024
Patients with Stable and Acute Exacerbation of Bronchiectasis Present Increased Platelet Activation
Mendez, R; (...); Menendez, R
Meeting Abstract. 2019
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
Figueira-Goncalves, Juan Marco; (...); Menendez, Rosario
Article. 10.2147/COPD.S428316. 2023
PES Score validation in a multicenter Cohort of patients with community-acquired pneumonia
Ceccato, Adrian; (...); Torres, Antoni
Meeting Abstract. 10.1183/13993003.congress-2019.OA3305. 2019
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
Wang, XJ; (...); Barreiro, E
Article. 10.3390/ijerph18168431. 2021
Platelet activation is boosted early in community-acquired pneumonia and sustained until 30 days later
Mendez, R; (...); Menendez, R
Meeting Abstract. 10.1183/13993003.congress-2018.PA2633. 2018
Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016-2020: The CAPA Study
Menendez, Rosario; (...); Gessner, Bradford D.
Article. 10.3390/microorganisms11112781. 2023
Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome
Menéndez R; (...); Torres A
Article. 10.1016/j.jinf.2016.08.001. 2016
Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences
Polverino, E; (...); Torres, A
Article. 10.1016/j.jinf.2018.04.006. 2018
Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.
Huerta A; (...); Torres A
Article. 10.1378/chest.13-0488. 2013
Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics
Huerta, Arturo; (...); Torres, Antoni
Article. 2013
Predicting In-Hospital Treatment Failure (<= 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids
Crisafulli E; (...); Menéndez R
Article. 10.3109/15412555.2015.1057276. 2016
Predicting treatment failure in patients with community acquired pneumonia: a case-control study
Martin-Loeches I; (...); Torres A
Article. 10.1186/1465-9921-15-75. 2014
Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia
Montull B; (...); NAC Calidad Group
Article. 10.1371/journal.pone.0145929. 2016
Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia.
Article. 2016
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study.
Benítez ID; (...); Barbé F
Article. 10.1016/j.lanepe.2022.100422. 2022
Puede reducir la mortalidad de los pacientes con EPOC la profilaxis domiciliaria de la enfermedad tromboembólica venosa?
Modesto-Alapont M; (...); Perpiñá-Tordera M
Article. 10.1016/S1579-2129(06)60131-6. 2006
Pulmonary nocardiosis: risk factors and outcomes.
Martínez Tomás R; (...); Gobernado Serrano M
Article. 10.1111/j.1440-1843.2007.01078.x. 2007
Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis.
Martínez R, Reyes S, Menéndez R
Article. 10.1097/MCP.0b013e3282f85dd3. 2008
Quality Indicators of Asthma Care Derived From the Spanish Guidelines for Asthma Management (GEMA 4.0): A Multidisciplinary Team Report
Quirce, S; (...); ASMAFORUM II Group
Editorial Material. 10.18176/jiaci.0121. 2017
Reduced Diffusion Capacity in COVID-19 Survivors.
Mendez, Raul; (...); Menendez, Rosario
Article. 10.1513/AnnalsATS.202011-1452RL. 2021
Reply to "Dual Antibiotic Therapy for Outpatient Management of Community-Acquired Pneumonia?"
Menéndez R, Méndez R, Torres A
Letter. 10.1016/j.arbres.2020.06.016. 2020
Research in community-acquired pneumonia: the next steps
Torres, A, Martin-Loeches, I, Menendez, R
Editorial Material. 10.1007/s00134-017-4774-4. 2017
Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors.
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1111/joim.13642. 2023
RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients.
Martinez-García MA; (...); Olveira C
Article. 10.1016/j.arbres.2019.12.021. 2021
Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study
Olmos, LF; (...); MENENDEZ, R
Meeting Abstract. 10.1183/13993003.congress-2020.4100. 2020
Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations
Menendez, R; (...); Torres, A
Article. 10.1186/s12879-017-2754-5. 2017
Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality.
Reyes S; (...); Menéndez R
Article. 10.1016/j.rmed.2011.04.011. 2011
Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia.
Molinos L; (...); Torres A
Article. 10.1513/AnnalsATS.201505-304OC. 2015
Sepsis-3 In Community-Acquired Pneumonia: A Clinical Decision-Making Study
Ranzani, OT; (...); Torres, A
Meeting Abstract. 2017
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia.
Ramírez P; (...); Torres A
Article. 10.1183/09031936.00086707. 2008
Severity and outcomes of community acquired pneumonia in asthmatic patients
Terraneo S; (...); Torres A
Article. 10.1016/j.rmed.2014.09.001. 2014
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients.
Liapikou A; (...); Torres A
Article. 10.1183/09031936.00067111. 2012
Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors.
Méndez R; (...); Menéndez R
Article. 10.1111/joim.13262. 2021
Simultaneous Depression of Immunological Synapse and Endothelial Injury is Associated with Organ Dysfunction in Community-Acquired Pneumonia
Menendez, R; (...); Bermejo-Martin, JE
Article. 10.3390/jcm8091404. 2019
Social Determinants of Respiratory Health: Opening the Door.
Perpina-Tordera, Miguel, Almonacid, Carlos
Editorial Material. 10.1016/j.arbres.2024.07.022. 2024
Soluble P-Selectin in Acute Exacerbations and Stable Bronchiectasis in Adults
Mendez, R; (...); Menendez, R
Letter. 10.1513/AnnalsATS.201902-140RL. 2019
Stability in community-acquired pneumonia: one step forward with markers?
Menéndez R; (...); Torres A
Article. 10.1136/thx.2009.118612. 2009
Systemic Biomarkers in Bronchiectasis Exacerbations: A Comparison Between Hospitalized and Outpatients
Amara Elori, I.; (...); Menendez, R.
Meeting Abstract. 2018
Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.
Polverino E; (...); Torres A
Article. 10.1111/resp.12013. 2013
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact ofPseudomonas aeruginosa
MENENDEZ, R; (...); Torres, A
Article. 10.3390/jcm9082631. 2020
Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study.
Wang X; (...); Barreiro E
Article. 10.3390/biomedicines10020225. 2022
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; (...); Torres A
Article. 10.1378/chest.12-1684. 2013
Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study.
Ramírez P; (...); Torres A
Article. 10.1097/CCM.0b013e31819fec5f. 2009
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Serrano, Leyre
Article. 10.3390/jcm12216864. 2023
The evolution and distribution of pneumococcal serotypes in adults hospitalized with community acquired pneumonia in Spain using serotype specific urinary antigen detection test: the CAPA study, 2011-2018.
Torres, Antoni; (...); Gessner, Bradford D
Article. 10.1093/cid/ciab307. 2021
Thrombocytosis is a marker of poor outcome in community-acquired pneumonia.
Prina E; (...); Torres A
Article. 10.1378/chest.12-1235. 2013
Tobacco Smoking Increases the Risk for Death From Pneumococcal Pneumonia
Bello S; (...); Ruiz-Manzano J
Article. 10.1378/chest.13-2853. 2014
Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia.
Méndez R; (...); Menéndez R
Article. 10.1055/s-0043-1778139. 2024
Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors
Crisafulli, Ernesto; (...); Torres, Antoni
Meeting Abstract. 2014
Understanding the Host in the Management of Pneumonia An Official American Thoracic Society Workshop Report
Dela Cruz, Charles S.; (...); Amer Thoracic Soc Assembly Pulm In
Article. 10.1513/AnnalsATS.202102-209ST. 2021
Validation of a Prediction Score for Drug-resistant Microorganisms in Community-Acquired Pneumonia.
Ceccato A; (...); Torres A
Article. 10.1513/AnnalsATS.202005-558OC. 2020
Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia.
Cilloniz, Catia; (...); Torres, Antoni
Article. 10.1016/j.arbres.2022.08.012. 2023
Validation of the PES Prediction Score for the Causative Different to Treat Microorganisms in Community-Acquired Pneumonia
Ceccato, A.; (...); Torres, A.
Meeting Abstract. 2020
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
Bermejo-Martin JF; (...); Kelvin DJ
Article. 10.1186/s13054-020-03398-0. 2020
What pulmonologists think about the asthma-COPD overlap syndrome
Miravitlles, M; (...); Plaza, V
Article. 10.2147/COPD.S88667. 2015
Campos de Estudio
Cita
INVESTIGACION COOPERATIVA DE ENFERMEDADES RESPIRATORIAS. (PI05/0583). INSTITUTO DE SALUD CARLOS III. 2006-2015. IP:ROSARIO MENÉNDEZ VILLANUEVA.